- Home
- FMX vs TEVA Comparison
FMX vs TEVA Comparison
Compare FMX & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FMX | TEVA |
|---|---|---|
| Founded | 1890 | 1901 |
| Country | Mexico | Israel |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.4B | 40.5B |
| IPO Year | 1998 | 1996 |
Fundamental Metrics
Financial Performance| Metric | FMX | TEVA |
|---|---|---|
| Price | $128.65 | $39.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 13 |
| Target Price | ★ $135.64 | $47.58 |
| AVG Volume (30 Days) | 515.7K | ★ 5.5M |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | ★ 5.21% | N/A |
| EPS Growth | N/A | ★ 183.45 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.44 | N/A |
| Revenue Next Year | $7.62 | $3.39 |
| P/E Ratio | $40.94 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $90.87 | $19.00 |
| 52 Week High | $141.47 | $42.02 |
Technical Indicators
Market Signals| Indicator | FMX | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 68.65 | 46.95 |
| Support Level | $121.06 | $38.28 |
| Resistance Level | $131.18 | $40.79 |
| Average True Range (ATR) | 2.63 | 1.00 |
| MACD | 1.13 | -0.20 |
| Stochastic Oscillator | 87.25 | 30.77 |
Price Performance
Historical ComparisonAbout FMX Fomento Economico Mexicano S.A.B. de C.V.
Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up over 70% of total company revenue and over 90% of profits in 2025.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.